Frantz Viral Therapeutics, LLC
4 clinical trials · Sponsor
◉ Watch Frantz Viral Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants (NCT06206564) | Frantz Viral Therapeutics, LLC | 2024-01-12 |
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) (NCT06075264) | Frantz Viral Therapeutics, LLC | 2023-12-06 |
| Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL (NCT05555862) | Frantz Viral Therapeutics, LLC | 2023-02-10 |
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3) (NCT04098744) | Frantz Viral Therapeutics, LLC | 2020-09-09 |
Track Frantz Viral Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.